BAXNYSESEC EDGAREDGAR

BAXTER INTERNATIONAL INC

Surgical & Medical Instruments & Apparatus·DEERFIELD, IL·FY end 12/31·CIK 10456

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$11.2B$2.8B$3.9B$15.1B$12.8B
Gross Profit$3.4B$959.0M$1.5B$5.4B$5.1B
Operating Income-$308.0M$14.0M$390.0M-$1.9B$1.7B
Net Income-$957.0M-$512.0M$245.0M-$2.4B$1.3B
Operating CF$845.0M$1.0B$1.7B$1.2B$2.2B
Capex
Free Cash Flow
Buybacks$0$0$32.0M$600.0M
Dividends$348.0M$590.0M$586.0M$573.0M$530.0M
Gross Margin30.1%34.8%37.9%35.7%39.9%
Operating Margin-2.7%0.5%10.0%-12.9%13.4%
Net Margin-8.5%-18.6%6.3%-16.1%10.0%
FCF Margin
R&D / Revenue4.6%21.4%17.2%4.0%4.2%
Effective Tax-78.2%-12.8%33.0%-2.9%12.3%
Debt / Equity1.541.891.652.861.96
Buybacks / FCF

Peer comparison

Surgical & Medical Instruments & Apparatus · 5 peers
CEO Pay Ratio
BAX
257:1
BSX
348:1
SYK
264:1
MMM
316:1
PODD
213:1
BDX
374:1
CEO total comp
BAX
$18M
BSX
$24M
SYK
$21M
MMM
$21M
PODD
$19M
BDX
$17M
Net Margin
BAX
-8.5%
BSX
SYK
11.8%
MMM
13.0%
PODD
9.1%
BDX
7.7%